It’s hard to believe it’s been over 10 years since the first Erice statement in 2016, which laid out 10 key points summarising the essential components of cure and care for childhood cancer survivors! In Nov 2016, 65 pediatric cancer experts from 17 European countries and North America, including many members of the PanCareLIFE team, […]
On 21 June, members of the German press joined a tour of three EU projects in Mainz, which included PanCareLIFE. The tour was organised by the Regional Representation of the European Commission in Bonn. During an hour-long session, the impact of PanCareLIFE’s research into fertility and hearing impairment late effects in long-term survivors was described, as well as […]
It’s been a busy few months for Childhood Cancer International! Learn about their work to put pediatric cancer on the EU agenda and more here in their latest newsletter.
On Thursday, June 21, 2018, PanCareLIFE will be featured at a press conference highlighting EU-funded projects in the Rhineland-Palatinate region. Three EU-funded projects, which have received a total of around 11 million euros from the EU, will feature: In the PanCareLIFE project, researchers are looking at late effects, such as infertility and hearing loss among long-term survivors of childhood cancer. Long-term survivors of […]
Check out our latest open access publication in Critical Reviews in Oncology/Hematology!
The March edition of the FNM newsletter includes a feature on PanCareLIFE. The article describes how the paradigm in childhood oncology has changed from acute care to cure cancer to chronic care, where there is a focus on cure but also on prevention of late effects and their lifelong, informed management. Lifelong management relies on systematic research […]
Our latest newsletter is now out – have a look!
Check out the latest open access publication from our sister project PanCareSurFup in the European Journal of Epidemiology!
The PanCareLIFE final conference will be held 26 October 2018 in Paris – save the date!
PanCareLIFE researchers at UNIBE have just published a new paper ‘Audiological monitoring in Swiss childhood cancer patients’, funded in part by PanCareLIFE. Pediatric Blood & Cancer, 65(3) e26877, DOI: 10.1080/08880018.2017.1323985 Abstract Background Full audiological monitoring is the best strategy to detect hearing loss early and to provide timely intervention in the absence of a clinical method of […]
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602030. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.
